D Pharm LTD.

About:

D-Pharm is a drug-development company.

Top Investors: Vertex Ventures, Gemini Israel Ventures, Care Capital, Cowen Group, Ramius

Description:

D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.

Total Funding Amount:

$37.3M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Rehovot, HaMerkaz, Israel

Founded Date:

1993-01-01

Contact Email:

thorovitz(AT)dpharm.com

Founders:

Alexander Kozak

Number of Employees:

1-10

Last Funding Date:

2015-01-22

IPO Status:

Public

Industries: